tiprankstipranks
Trending News
More News >
OrbusNeich Medical Group Holdings Limited (HK:6929)
:6929
Hong Kong Market
Advertisement

OrbusNeich Medical Group Holdings Limited (6929) Ratios

Compare
0 Followers

OrbusNeich Medical Group Holdings Limited Ratios

HK:6929's free cash flow for Q2 2025 was $0.67. For the 2025 fiscal year, HK:6929's free cash flow was decreased by $ and operating cash flow was $0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
12.21 9.77 13.20 14.31 1.34
Quick Ratio
9.95 8.60 11.96 12.51 0.80
Cash Ratio
7.97 7.18 9.62 10.69 0.27
Solvency Ratio
1.21 1.21 0.79 >-0.01 0.16
Operating Cash Flow Ratio
0.16 0.65 0.98 1.25 0.23
Short-Term Operating Cash Flow Coverage
0.00 5.44 0.00 0.00 0.32
Net Current Asset Value
$ 327.44M$ 307.24M$ 285.78M$ 149.94M$ 5.72M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.02 0.01 0.25 0.50
Debt-to-Equity Ratio
0.01 0.02 0.01 0.37 1.48
Debt-to-Capital Ratio
0.01 0.02 0.01 0.27 0.60
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.26 0.23
Financial Leverage Ratio
1.09 1.11 1.09 1.47 2.97
Debt Service Coverage Ratio
0.00 11.29 16.29 0.92 0.30
Interest Coverage Ratio
0.00 281.26 14.40 3.47 6.20
Debt to Market Cap
0.00 <0.01 0.00 0.09 0.07
Interest Debt Per Share
<0.01 <0.01 <0.01 0.13 0.09
Net Debt to EBITDA
-6.39 -4.60 -8.30 -13.03 2.86
Profitability Margins
Gross Profit Margin
67.91%69.22%67.57%69.70%65.58%
EBIT Margin
20.01%32.34%17.00%3.68%9.79%
EBITDA Margin
21.59%35.07%19.83%7.13%14.41%
Operating Profit Margin
19.66%25.96%15.40%16.69%9.83%
Pretax Profit Margin
24.83%32.25%15.93%-1.13%8.20%
Net Profit Margin
24.10%29.29%13.51%-3.82%7.99%
Continuous Operations Profit Margin
24.19%29.29%13.51%-3.82%7.99%
Net Income Per EBT
97.08%90.82%84.86%337.18%97.46%
EBT Per EBIT
126.29%124.26%103.41%-6.78%83.45%
Return on Assets (ROA)
9.12%10.99%5.27%-1.65%6.82%
Return on Equity (ROE)
10.14%12.23%5.73%-2.43%20.26%
Return on Capital Employed (ROCE)
7.97%10.66%6.44%7.71%18.04%
Return on Invested Capital (ROIC)
7.73%9.53%5.44%25.85%9.52%
Return on Tangible Assets
9.59%11.54%5.37%-1.70%7.29%
Earnings Yield
7.71%6.06%2.27%-0.66%1.04%
Efficiency Ratios
Receivables Turnover
3.78 4.05 4.23 4.34 3.36
Payables Turnover
10.32 9.84 10.91 16.23 22.33
Inventory Turnover
0.81 1.14 1.51 1.19 1.01
Fixed Asset Turnover
4.73 8.33 10.29 9.02 7.49
Asset Turnover
0.38 0.38 0.39 0.43 0.85
Working Capital Turnover Ratio
0.51 0.51 0.54 0.98 -1.75
Cash Conversion Cycle
514.41 372.18 294.66 367.39 452.26
Days of Sales Outstanding
96.63 90.06 86.23 84.04 108.57
Days of Inventory Outstanding
453.16 319.22 241.87 305.84 360.04
Days of Payables Outstanding
35.38 37.10 33.44 22.49 16.35
Operating Cycle
549.79 409.28 328.10 389.88 468.61
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 0.03 0.03 0.04 0.02
Free Cash Flow Per Share
<0.01 0.02 0.03 0.03 0.02
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.36 0.68 0.86 0.90 0.70
Dividend Paid and CapEx Coverage Ratio
1.56 3.08 7.03 9.57 3.37
Capital Expenditure Coverage Ratio
1.56 3.08 7.03 9.57 3.37
Operating Cash Flow Coverage Ratio
1.11 3.09 5.82 0.30 0.25
Operating Cash Flow to Sales Ratio
0.03 0.15 0.17 0.18 0.14
Free Cash Flow Yield
0.33%2.09%2.46%2.71%1.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
12.97 16.51 44.11 -152.32 96.27
Price-to-Sales (P/S) Ratio
3.12 4.84 5.96 5.81 7.69
Price-to-Book (P/B) Ratio
1.29 2.02 2.53 3.70 19.51
Price-to-Free Cash Flow (P/FCF) Ratio
299.75 47.86 40.59 36.87 76.40
Price-to-Operating Cash Flow Ratio
107.61 32.32 34.81 33.02 53.74
Price-to-Earnings Growth (PEG) Ratio
10.55 0.23 -0.09 0.94 38.51
Price-to-Fair Value
1.29 2.02 2.53 3.70 19.51
Enterprise Value Multiple
8.08 9.19 21.76 68.47 56.26
Enterprise Value
294.52M 496.06M 590.56M 568.71M 717.18M
EV to EBITDA
8.08 9.19 21.76 68.47 56.26
EV to Sales
1.75 3.22 4.32 4.88 8.11
EV to Free Cash Flow
167.43 31.89 29.39 30.98 80.49
EV to Operating Cash Flow
60.07 21.54 25.20 27.74 56.62
Tangible Book Value Per Share
0.47 0.42 0.44 0.31 0.05
Shareholders’ Equity Per Share
0.50 0.44 0.45 0.32 0.06
Tax and Other Ratios
Effective Tax Rate
0.03 0.09 0.15 -2.37 0.03
Revenue Per Share
0.20 0.18 0.19 0.20 0.15
Net Income Per Share
0.05 0.05 0.03 >-0.01 0.01
Tax Burden
0.97 0.91 0.85 3.37 0.97
Interest Burden
1.24 1.00 0.94 -0.31 0.84
Research & Development to Revenue
0.11 0.10 0.10 0.10 0.14
SG&A to Revenue
0.14 0.12 0.16 0.17 0.16
Stock-Based Compensation to Revenue
>-0.01 0.00 <0.01 0.01 0.00
Income Quality
0.12 0.51 1.08 -15.55 1.75
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis